
| Serial Number | 99318283 |
| Word Mark | DESIGN. ANALYZE. ADVANCE. |
| Filing Date | Monday, August 4, 2025 |
| Status | 686 - PUBLISHED FOR OPPOSITION |
| Status Date | Tuesday, April 28, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, April 28, 2026 |
| Goods and Services | Representation of clients in biomedical and pharmaceutical regulatory proceedings |
| NOT AVAILABLE | "DESIGN" and "ANALYZE" |
| Pseudo Mark | DESIGN ANALYZE ADVANCE |
| Goods and Services | Promoting public awareness of clinical trial results, namely, reporting and presentation of clinical trial results; Providing consulting services in the field of regulatory submission management to medical, biopharmaceutical and biotechnology companies to assist them with the submission of clinical trial results for applications for new pharmaceuticals and medical devices with governmental regulatory bodies; Regulatory submission management, namely, responding to inquiries regarding clinical trials from governmental regulatory bodies; Customer services, namely, responding to participant inquiries for others regarding clinical trials |
| Goods and Services | Consulting services for pharmaceutical, medical device, biotechnology, and medical research industries; consulting services in the field of expert review of proposed clinical trial design; software as a service (SaaS) featuring software for statistical analysis and simulation tools for clinical trial design, analysis, and optimization; providing an online non-downloadable computer software platform for running in vivo studies; providing an online non-downloadable computer software platform for running in silico studies; data modeling and statistical consulting services for the pharmaceutical, medical device, biotechnology, and medical research industries; design, development and implementation of software for in vivo simulations; design, development and implementation of software for in silico simulations |
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, August 4, 2025 |
| Primary Code | 035 |
| First Use Anywhere Date | Thursday, July 24, 2025 |
| First Use In Commerce Date | Thursday, July 24, 2025 |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, August 4, 2025 |
| Primary Code | 042 |
| First Use Anywhere Date | Thursday, July 24, 2025 |
| First Use In Commerce Date | Thursday, July 24, 2025 |
| International Class | 045 - Legal services; security services for the protection of property and individuals; personal and social services rendered by others to meet the needs of individuals. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, August 4, 2025 |
| Primary Code | 045 |
| First Use Anywhere Date | Thursday, July 24, 2025 |
| First Use In Commerce Date | Thursday, July 24, 2025 |
| Party Name | BIOMEDICAL STATISTICAL CONSULTING IP LLC |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | PHILADELPHIA, PA 19103 US |
| Party Name | BIOMEDICAL STATISTICAL CONSULTING IP LLC |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | PHILADELPHIA, PA 19103 US |
| Event Date | Event Description |
| Monday, August 4, 2025 | NEW APPLICATION ENTERED |
| Monday, August 4, 2025 | APPLICATION FILING RECEIPT MAILED |
| Thursday, December 11, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, December 17, 2025 | ASSIGNED TO EXAMINER |
| Friday, March 20, 2026 | NON-FINAL ACTION WRITTEN |
| Friday, March 20, 2026 | NON-FINAL ACTION E-MAILED |
| Friday, March 20, 2026 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, March 30, 2026 | EXAMINERS AMENDMENT -WRITTEN |
| Monday, March 30, 2026 | EXAMINERS AMENDMENT E-MAILED |
| Monday, March 30, 2026 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Monday, March 30, 2026 | EXAMINER'S AMENDMENT ENTERED |
| Monday, March 30, 2026 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, April 22, 2026 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, April 28, 2026 | PUBLISHED FOR OPPOSITION |
| Tuesday, April 28, 2026 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |